Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-07-19
2005-07-19
Morris, Patricia L. (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S332500
Reexamination Certificate
active
06919357
ABSTRACT:
Aspects of the present invention are directed towards compounds of Formula I for the treatment of human erectile disorders including erectile dysfunction in men.wherein:R1is hydrogen, halo, hydroxy, nitro, cyano, phenyl, trifluoromethyl, C1-C6alkyl, C1-C6alkoxy, carboxy, amino, cyclohexyl, C1-C6alkylamino, or (C1-C6alkyl)2amino;R2is hydrogen, halo, hydroxy, nitro, cyano, trifluoromethyl, C1-C6alkyl, C1-C6alkoxy, carboxy, amino, C1-C6alkylamino, or (C1-C6alkyl)2amino;R3is a group of the formulaR4is hydrogen or C1-C6alkyl;R5is hydrogen, halo, hydroxy, nitro, cyano, phenyl, trifluoromethyl, C1-C6alkyl, C1-C6alkoxy, carboxy, amino, C1-C6alkylamino, or (C1-C6alkyl)2amino; andR6is hydrogen, halo, hydroxy, nitro, cyano, trifluoromethyl, C1-C6alkyl, C1-C6alkoxy, carboxy, amino, C1-C6alkylamino, or (C1-C6alkyl)2amino;or pharmaceutically acceptable salts thereof.
REFERENCES:
patent: 5731339 (1998-03-01), Lowrey
J. of Urology vol. 159, 1214-16, 1998; Becker et al.; Oral Pentolamine as Treatment for Erectile Dysfunction.
Int. J. of Impotence Research vol. 6, 37-41, 1994, Zorgniotti, A.W.; Experience with Buccal Phentolamine Mesylate for Impotence.
J. of Sex and Marital Therapy, vol. 25, 137-144, 1999; Rosen et al.; Oral Phentolamine and Female Sexual Arousal Disorder.
Int. J. of Impotence Research, vol. 10, 215-223, 1998; Traish et al.; Phentolamine Mesylate Relaxes Penile Covpus Cavernosum Tissue by Adrenergic and Non-adrenergic Mechanisms.
Hong Seoung-Soo
Miller Duane D.
Molecular Design International Inc.
Morris Patricia L.
LandOfFree
α adrenergic agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with α adrenergic agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and α adrenergic agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3419205